Crystal structures of agonist-bound human cannabinoid receptor CB1

被引：0

作者：

Tian Hua

Kiran Vemuri

Spyros P. Nikas

Robert B. Laprairie

Yiran Wu

Lu Qu

Mengchen Pu

Anisha Korde

Shan Jiang

Jo-Hao Ho

Gye Won Han

Kang Ding

Xuanxuan Li

Haiguang Liu

Michael A. Hanson

Suwen Zhao

Laura M. Bohn

Alexandros Makriyannis

Raymond C. Stevens

Zhi-Jie Liu

机构：

[1] iHuman Institute,Department of Chemistry and Chemical Biology

[2] ShanghaiTech University,Departments of Molecular Medicine and Neuroscience

[3] National Laboratory of Biomacromolecules,Departments of Biological Sciences and Chemistry

[4] Institute of Biophysics,Complex Systems Division

[5] Chinese Academy of Sciences,undefined

[6] University of Chinese Academy of Sciences,undefined

[7] Center for Drug Discovery,undefined

[8] Department of Pharmaceutical Sciences,undefined

[9] Northeastern University,undefined

[10] The Scripps Research Institute,undefined

[11] Bridge Institute,undefined

[12] University of Southern California,undefined

[13] School of Life Science and Technology,undefined

[14] ShanghaiTech University,undefined

[15] Beijing Computational Science Research Center,undefined

[16] GPCR Consortium,undefined

来源：

Nature | 2017年 / 547卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Crystal structures of the human cannabinoid receptor 1 (CB1) bound to the agonists AM11542 and AM841 reveal notable structural rearrangements upon receptor activation, and this flexibility may be a common feature among other G-protein-coupled receptors.

引用

页码：468 / 471

页数：3

共 50 条

[21] An aromatic microdomain at the cannabinoid CB1 receptor constitutes an agonist/inverse agonist binding region
McAllister, SD
Rizvi, G
Anavi-Goffer, S
Hurst, DP
Barnett-Norris, J
Lynch, DL
Reggio, PH
Abood, ME
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (24) : 5139 - 5152
[22] Hemopressin is an inverse agonist of CB1 cannabinoid receptors
Heimann, Andrea S.
Gomes, Lvone
Dale, Camila S.
Pagano, Rosana L.
Gupta, Achla
de Souza, Laura L.
Luchessi, Augusto D.
Castro, Leandro M.
Giorgi, Renata
Rioli, Vanessa
Ferro, Elmer S.
Devi, Lakshmi A.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (51) : 20588 - 20593
[23] Induction of CB1 cannabinoid receptor by inflammation in primary afferent neurons facilitates antihyperalgesic effect of peripheral CB1 agonist
Amaya, Fumimasa
Shimosato, Goshun
Kawasaki, Yasuhiko
Hashimoto, Satoru
Tanaka, Yoshifumi
Ji, Ru-Rong
Tanaka, Masaki
PAIN, 2006, 124 (1-2) : 175 - 183
[24] Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors
Leggett, JD
Aspley, S
Beckett, SRG
D'Antona, AM
Kendall, DA
Kendall, DA
BRITISH JOURNAL OF PHARMACOLOGY, 2004, 141 (02) : 253 - 262
[25] Central antinociception induced by μ-opioid receptor agonist morphine, but not δ- or κ-, is mediated by cannabinoid CB1 receptor
Pacheco, Daniela da Fonseca
Klein, Andre
Perez, Andrea Castro
da Fonseca Pacheco, Cinthia Mara
de Francischi, Janetti Nogueira
Lopes Reis, Glaucia Maria
Gama Duarte, Igor Dimitri
BRITISH JOURNAL OF PHARMACOLOGY, 2009, 158 (01) : 225 - 231
[26] Voltage dependence of the cannabinoid CB1 receptor
Goldberger, Esty
Tauber, Merav
Ben-Chaim, Yair
FRONTIERS IN PHARMACOLOGY, 2022, 13
[27] Allosteric Modulation of Cannabinoid CB1 Receptor
Ross, Ruth A.
Baillie, Gemma L.
Pertwee, Roger G.
FASEB JOURNAL, 2012, 26
[28] Internalization and recycling of the CB1 cannabinoid receptor
Hsieh, C
Brown, S
Derleth, C
Mackie, K
JOURNAL OF NEUROCHEMISTRY, 1999, 73 (02) : 493 - 501
[29] Allosteric modulation of the cannabinoid CB1 receptor
Price, MR
Baillie, GL
Thomas, A
Stevenson, LA
Easson, M
Goodwin, R
McLean, A
McIntosh, L
Goodwin, G
Walker, G
Westwood, P
Marrs, J
Thomson, F
Cowley, P
Christopoulos, A
Pertwee, RG
Ross, RA
MOLECULAR PHARMACOLOGY, 2005, 68 (05) : 1484 - 1495
[30] Signal transduction of the CB1 cannabinoid receptor
Turu, Gabor
Hunyady, Laszlo
JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2010, 44 (02) : 75 - 85

← 1 2 3 4 5 →